MarketHealth CareHealth Care Equipment & SuppliesHealth Care Equipment
THERALASE TECHNOLOGI

TLTFF

$0.27Apr 26, 2021Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$50M
MVM
-$0.7M
TD Variance
-3.680

Every news event mapped to its market reaction — 31 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-04-10+25.4%newsTMX NewsfileTheralase(R) Closes $CAN 2.66 Million Financing
2026-04-10+25.4%newsTMX NewsfileTheralase(R) Closes $CAN 2.66 Million Financing - TMX Newsfile
2026-02-04+16.7%newsSimply Wall St.TSX Penny Stock Spotlight: Fox River Resources And Two Others To Consider
2026-01-02+15.8%analystYahoo FinanceAnalysts Expect Breakeven For Theralase Technologies Inc. (CVE:TLT) Before Long - Yahoo Finance
2022-06-28-12.7%newsSeeking AlphaTheralase expands Intellectual Property portfolio
2024-12-04+10.7%earningsSeeking AlphaTheralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call Transcript
2026-02-17-9.8%newsTMX NewsfileTheralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2025-12-23-9.1%newsSeeking AlphaTheralase(R) closes $1.3M non-brokered private placement
2024-03-27-8.5%newsSeeking AlphaTheralase Technologies reports FY results
2025-03-19-7.9%earningsSeeking AlphaTheralase Technologies Inc. (TLTFF) Q4 2024 Earnings Call Transcript
2024-06-06+7.8%earningsSeeking AlphaTheralase Technologies Inc. (TLTFF) Q1 2024 Earnings Call Transcript
2022-11-30-7.4%earningsSeeking AlphaTheralase Technologies reports Q3 results
2023-11-30+6.7%newsSeeking AlphaTheralase Technologies reports results for the nine month period ended September
2026-02-20+5.6%newsTMX NewsfileCorrecting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-03-10+5.5%newsTMX NewsfileTheralase(R) Closes $1.1 M Non-Brokered Private Placement
2026-03-10+5.5%newsStock TitanBladder cancer trial gets $1.1M boost from Theralase financing - Stock Titan
2025-02-13+4.2%newsStock TitanGroundbreaking Herpes Treatment Success: Theralase's Ruvidar Shows 100% Healing Rate - Stock Titan
2026-03-02-3.9%newsTMX NewsfileLight-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
2025-04-10+2.7%newsStock TitanRevolutionary Once-Daily Herpes Treatment Shows 5X Better Results Than Current Options - Stock Titan
2026-04-13+2.6%newsTMX NewsfileTheralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
2026-04-13+2.6%newsStock TitanAll treated animals stayed cancer-free in Theralase bladder study - Stock Titan
2025-03-24-2.0%newsStock TitanRevolutionary Herpes Drug Shows Superior Results: Challenges $2.8B Market Leaders - Stock Titan
2025-12-12+1.2%newsSeeking AlphaTheralase commences C$ 2M non-brokered private placement
2026-03-17+1.1%newsTMX NewsfileTheralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
2026-03-17+1.1%newsStock TitanLab study: Theralase's Ruvidar wipes out 99.999999% of HSV-1 - Stock Titan
2024-04-03+1.1%earningsSeeking AlphaTheralase Technologies Inc. (TLTFF) Q4 2023 Earnings Call Transcript
2025-04-25-0.8%newsStock TitanTLTFF Stock Price, News & Analysis - Stock Titan
2026-03-09-0.7%newsTMX NewsfileTheralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
2025-06-09-0.7%earningsSeeking AlphaTheralase Technologies Inc. (TLTFF) Q1 2025 Earnings Call Transcript
2024-08-21+0.4%earningsSeeking AlphaTheralase Technologies Inc. (TLTFF) Q2 2024 Earnings Call Transcript
2026-02-10+0.3%newsTMX NewsfileTheralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
tickerdossier.comtickerdossier.substack.com